## Abstract After inoculation of the Schmidt‐Ruppin strain of Rous sarcoma virus (SR‐RSV) into a series of newborn rats (strain R/F) sarcomas developed in 47% of the animals, half of which also had hemorrhagic‐cystic lesions. In 18% such hemorrhagic cysts occurred without demonstrable tumors, while
Establishment of paired tumor cells and autologous virus-transformed cell lines to define humoral immune responses in melanoma and sarcoma patients
✍ Scribed by R. E. Saxton; R. F. Irie; S. Ferrone; M. A. Pellegrino; D. L. Morton
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- French
- Weight
- 809 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Peripheral blood lymphocytes and skin fibroblasts from 12 cancer patients were infected with Epstein‐Barr virus (EBV) or SV40 virus. The EBV‐trans‐formed lymphoblasts and SV40‐transformed fibro‐blasts were grown as continuous cell lines and expressed the same histocompatibility antigens as tumor cell lines established from the same cancer patients. Sera from 350 melanoma and 195 sarcoma patients were tested for antibody reactive with membrane antigens on three of these tumor cell lines (two melanomas and one sarcoma) by immune adherence (IA) and indirect immunofluorescence (IMI) assays. Antibodies to HLA and other non‐tumor‐related antigens were completely removed from the most reactive sera by quantitative absorption with 4 × 10^7^ lymphoblasts or 10^7^ transformed fibroblasts autologous to the tumor target cells. These paired cell lines were used to monitor humoral immune responses in melanoma and sarcoma patients receiving allogeneic tumor cell vaccines.
📜 SIMILAR VOLUMES
Ten synthetic peptides containing 18-22 residues deduced from the amino-acid sequences of the EBV-encoded latentinfection-associated membrane protein (LMP) and the 2 principal nuclear antigens, EBNA-I and EBNA-2, were tested for their ability to induce lymphokine release from sensitized Tcells of EB